Skip to main content
ARX
NYSE Finance

Director Nancy Hasley Notices Sale of 270,000 Shares (~$5.37M) Near 52-Week High

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Insurance Stocks · Financial
Sentiment info
Negative
Importance info
7
Price
$19.85
Mkt Cap
$4.311B
52W Low
$9.18
52W High
$19.91
52W Position info
116% above low
Off High info
at 52W high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

ARX has more than doubled off its 52-week low of $9.18.

Summary

Director Nancy Hasley filed notice to sell 270,000 shares (~$5.37M) of founder stock, after 20,489 shares already sold under a 10b5-1 plan for $400,838.72. The notice lands with the stock near its 52-week high and the $20.25-per-share Thoma Bravo buyout pending.


Key Events · Ownership and Investor Activity · ARX

  • Director Notices 270,000-Share Sale

    Nancy Hasley filed a Form 144 to sell 270,000 common shares with an aggregate market value of $5,367,681.00 through Morgan Stanley Smith Barney.

  • Founder Stock, Prior 10b5-1 Sales

    The shares are founder stock acquired 07/23/2025; 20,489 shares were already sold on 08/13/2026 for gross proceeds of $400,838.72 under a 10b5-1 plan.

  • Sale Near 52-Week High

    The notice comes with the stock at $19.85, just below its 52-week high of $19.91, and near the $20.25-per-share cash price in the pending Thoma Bravo acquisition.

  • Buyout Vote Pending

    The preliminary proxy filed 2026-10-30 sets a special meeting on the $20.25-per-share cash sale to Thoma Bravo; this notice does not alter those terms.


Analysis · ARX · Finance

A director is proposing to sell 270,000 shares worth roughly $5.37M — a meaningful disposition from an insider, filed the same day as the notice and with the stock trading near its 52-week high of $19.91. The sale is tied to founder stock acquired in July 2025 and follows 20,489 shares already sold under a 10b5-1 plan for $400,838.72. With the company's $20.25-per-share cash sale to Thoma Bravo pending and a special meeting set by the preliminary proxy filed 2026-10-30, insider selling into the deal price is worth noting but is not a change to the transaction terms.

How filings like this one have moved

In the 30 days to Nov 12, 2026, 37% of the 3595 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, ARX was trading at $19.85 on NYSE in the Finance sector, with a market capitalization of approximately $4.3B. The 52-week trading range was $9.18 to $19.91. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ARX - Latest Insights

ARX
Nov 12, 2026, 8:02 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $19.87
Real-time Price: $19.85 info
Change: -$0.020 (-0.10%) info
Market Cap: $4.311B info
ARX
Nov 12, 2026, 8:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $19.87
Real-time Price: $19.85 info
Change: -$0.020 (-0.10%) info
Market Cap: $4.311B info
ARX
Oct 30, 2026, 4:05 PM EDT
Filing Type: PREM14A
Importance Score:
8
Price at Filing: $19.82
Real-time Price: $19.85 info
Change: +$0.030 (+0.15%) info
Market Cap: $4.311B info
ARX
Aug 13, 2026, 9:15 PM EDT
Filing Type: DEFA14A
Importance Score:
9
Price at Filing: $19.49
Real-time Price: $19.85 info
Change: +$0.360 (+2%) info
Market Cap: $4.311B info
ARX
Aug 13, 2026, 9:14 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $19.49
Real-time Price: $19.85 info
Change: +$0.360 (+2%) info
Market Cap: $4.311B info